Mithyro 25/50/75/100 μg Tablets
PDF Leaflet Revision Date: 31 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for untreated hypothyroidism.
Dosage (summary)
Adults: Initially 50-100 u03bcg daily; adjust by 50 u03bcg every 3-4 weeks. Max: 100-300 u03bcg. Elderly: Start at 25-50 u03bcg.
Special Populations
- Elderly
- Paediatric population
- Patients with cardiac disease
Pregnancy & Breastfeeding
Monitor thyroid function; dosage may need adjustment during pregnancy. Excreted in breast milk.
Key Drug Interactions
- Warfarin
- Phenytoin
- Carbamazepine
- Digoxin
- Cholestyramine
Contraindications
- Untreated hyperthyroidism
- Hypersensitivity to levothyroxine
- Untreated adrenal insufficiency
- Acute myocardial infarction
Common side effects
- Hyperthyroidism
- Anginal pain
- Palpitations
- Nausea
- Hair loss
Counselling Points
- Take before breakfast
- Do not double doses
- Monitor for symptoms of hyperthyroidism
- Regular thyroid function tests required
Serious warnings
- Narrow therapeutic index
- Thyroid storm risk
- Monitor in cardiac patients
Important Disclaimer
The Mithyro 25/50/75/100 μg Tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
